Self-testing hailed as a ‘gamechanger’ in preventing cervical cancers for women who are reluctant to attend GP surgeries
More than 31,000 women in England will be given home smear tests as part of a trial that has been described as a “gamechanger” for cervical cancer screening.
It comes after charities raised concern about smear test delays during the pandemic. While cervical cancer screening has restarted, there is evidence that some women remain reluctant to attend appointments due to the risk of catching Covid-19.
